Richard Ronald 4
4 · Emergent BioSolutions Inc. · Filed Apr 29, 2020
Insider Transaction Report
Form 4
Richard Ronald
Director
Transactions
- Exercise/Conversion
Common Stock
2020-04-27$20.08/sh+7,893$158,491→ 24,288 total - Sale
Common Stock
2020-04-27$78.00/sh−7,893$615,654→ 16,395 total - Exercise/Conversion
Stock Options (Right to Buy)
2020-04-27$78.00/sh−7,893$615,654→ 0 totalExercise: $20.08Exp: 2021-05-19→ Common Stock (7,893 underlying)
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard.
- [F2]Consists of options granted under the company's stock incentive plan as amended and restated.
- [F3]The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.